Logo image of OLPX

OLAPLEX HOLDINGS INC (OLPX) Stock Fundamental Analysis

USA - NASDAQ:OLPX - US6793691089 - Common Stock

1.23 USD
+0.04 (+3.36%)
Last: 10/17/2025, 8:00:02 PM
1.23 USD
0 (0%)
After Hours: 10/17/2025, 8:00:02 PM
Fundamental Rating

5

Overall OLPX gets a fundamental rating of 5 out of 10. We evaluated OLPX against 36 industry peers in the Personal Care Products industry. OLPX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. OLPX has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

OLPX had positive earnings in the past year.
OLPX had a positive operating cash flow in the past year.
Each year in the past 5 years OLPX has been profitable.
In the past 5 years OLPX always reported a positive cash flow from operatings.
OLPX Yearly Net Income VS EBIT VS OCF VS FCFOLPX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2019 2020 2021 2022 2023 2024 100M 200M 300M

1.2 Ratios

OLPX has a Return On Assets of -0.08%. This is comparable to the rest of the industry: OLPX outperforms 44.44% of its industry peers.
OLPX has a Return On Equity of -0.15%. This is comparable to the rest of the industry: OLPX outperforms 52.78% of its industry peers.
OLPX has a Return On Invested Capital (2.54%) which is in line with its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for OLPX is below the industry average of 12.77%.
The 3 year average ROIC (8.40%) for OLPX is well above the current ROIC(2.54%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROIC 2.54%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
OLPX Yearly ROA, ROE, ROICOLPX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2019 2020 2021 2022 2023 2024 100 200 300 400

1.3 Margins

In the last couple of years the Profit Margin of OLPX has declined.
OLPX's Operating Margin of 10.97% is fine compared to the rest of the industry. OLPX outperforms 72.22% of its industry peers.
OLPX's Operating Margin has declined in the last couple of years.
OLPX has a better Gross Margin (70.81%) than 69.44% of its industry peers.
OLPX's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 10.97%
PM (TTM) N/A
GM 70.81%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
OLPX Yearly Profit, Operating, Gross MarginsOLPX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2019 2020 2021 2022 2023 2024 20 40 60

7

2. Health

2.1 Basic Checks

OLPX has a Return on Invested Capital (ROIC), which is just above the Cost of Capital (WACC), which means it is creating some value.
The number of shares outstanding for OLPX has been increased compared to 1 year ago.
The number of shares outstanding for OLPX has been increased compared to 5 years ago.
OLPX has a better debt/assets ratio than last year.
OLPX Yearly Shares OutstandingOLPX Yearly Shares OutstandingYearly Shares Outstanding 2019 2020 2021 2022 2023 2024 200M 400M 600M
OLPX Yearly Total Debt VS Total AssetsOLPX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.2 Solvency

OLPX has an Altman-Z score of 1.91. This is not the best score and indicates that OLPX is in the grey zone with still only limited risk for bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 1.91, OLPX is in line with its industry, outperforming 41.67% of the companies in the same industry.
The Debt to FCF ratio of OLPX is 3.63, which is a good value as it means it would take OLPX, 3.63 years of fcf income to pay off all of its debts.
With an excellent Debt to FCF ratio value of 3.63, OLPX belongs to the best of the industry, outperforming 80.56% of the companies in the same industry.
OLPX has a Debt/Equity ratio of 0.40. This is a healthy value indicating a solid balance between debt and equity.
OLPX has a Debt to Equity ratio of 0.40. This is comparable to the rest of the industry: OLPX outperforms 44.44% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Altman-Z 1.91
ROIC/WACC0.32
WACC7.93%
OLPX Yearly LT Debt VS Equity VS FCFOLPX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M

2.3 Liquidity

OLPX has a Current Ratio of 3.86. This indicates that OLPX is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of OLPX (3.86) is better than 86.11% of its industry peers.
A Quick Ratio of 3.20 indicates that OLPX has no problem at all paying its short term obligations.
With an excellent Quick ratio value of 3.20, OLPX belongs to the best of the industry, outperforming 86.11% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 3.86
Quick Ratio 3.2
OLPX Yearly Current Assets VS Current LiabilitesOLPX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

OLPX shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -42.86%.
The earnings per share for OLPX have been decreasing by -20.10% on average. This is quite bad
Looking at the last year, OLPX shows a decrease in Revenue. The Revenue has decreased by -3.44% in the last year.
The Revenue has been growing by 23.32% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%

3.2 Future

OLPX is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -4.14% yearly.
Based on estimates for the next years, OLPX will show a very strong growth in Revenue. The Revenue will grow by 29.95% on average per year.
EPS Next Y-30.45%
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue Next Year2.86%
Revenue Next 2Y2.86%
Revenue Next 3Y2.92%
Revenue Next 5Y29.95%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
OLPX Yearly Revenue VS EstimatesOLPX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 200M 400M 600M 800M 1B
OLPX Yearly EPS VS EstimatesOLPX Yearly EPS VS EstimatesYearly EPS VS Estimates 2021 2022 2023 2024 2025 2026 2027 0.1 0.2 0.3 0.4

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 15.38, which indicates a correct valuation of OLPX.
Based on the Price/Earnings ratio, OLPX is valued a bit cheaper than the industry average as 75.00% of the companies are valued more expensively.
The average S&P500 Price/Earnings ratio is at 27.40. OLPX is valued slightly cheaper when compared to this.
A Price/Forward Earnings ratio of 14.43 indicates a correct valuation of OLPX.
Based on the Price/Forward Earnings ratio, OLPX is valued a bit cheaper than 72.22% of the companies in the same industry.
OLPX's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 22.94.
Industry RankSector Rank
PE 15.38
Fwd PE 14.43
OLPX Price Earnings VS Forward Price EarningsOLPX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

72.22% of the companies in the same industry are more expensive than OLPX, based on the Enterprise Value to EBITDA ratio.
Based on the Price/Free Cash Flow ratio, OLPX is valued cheaply inside the industry as 88.89% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.45
EV/EBITDA 8.86
OLPX Per share dataOLPX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 1

4.3 Compensation for Growth

A cheap valuation may be justified as OLPX's earnings are expected to decrease with -4.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%

0

5. Dividend

5.1 Amount

OLPX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

OLAPLEX HOLDINGS INC

NASDAQ:OLPX (10/17/2025, 8:00:02 PM)

After market: 1.23 0 (0%)

1.23

+0.04 (+3.36%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)08-07 2025-08-07/bmo
Earnings (Next)11-05 2025-11-05/bmo
Inst Owners14.03%
Inst Owner Change0.01%
Ins Owners0.65%
Ins Owner Change7.58%
Market Cap820.51M
Analysts52.86
Price Target2.1 (70.73%)
Short Float %7.54%
Short Ratio10.33
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)14.18%
Min EPS beat(2)-32.11%
Max EPS beat(2)60.46%
EPS beat(4)2
Avg EPS beat(4)22%
Min EPS beat(4)-32.11%
Max EPS beat(4)69.03%
EPS beat(8)5
Avg EPS beat(8)16.36%
EPS beat(12)8
Avg EPS beat(12)10.16%
EPS beat(16)12
Avg EPS beat(16)10.46%
Revenue beat(2)2
Avg Revenue beat(2)2.62%
Min Revenue beat(2)1.35%
Max Revenue beat(2)3.89%
Revenue beat(4)3
Avg Revenue beat(4)2.54%
Min Revenue beat(4)-7.47%
Max Revenue beat(4)12.38%
Revenue beat(8)6
Avg Revenue beat(8)1.96%
Revenue beat(12)7
Avg Revenue beat(12)-0.92%
Revenue beat(16)11
Avg Revenue beat(16)0.66%
PT rev (1m)0%
PT rev (3m)-1.03%
EPS NQ rev (1m)1.34%
EPS NQ rev (3m)-6.26%
EPS NY rev (1m)25%
EPS NY rev (3m)14.4%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-7.65%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.48%
Valuation
Industry RankSector Rank
PE 15.38
Fwd PE 14.43
P/S 1.94
P/FCF 8.45
P/OCF 8.12
P/B 0.94
P/tB N/A
EV/EBITDA 8.86
EPS(TTM)0.08
EY6.5%
EPS(NY)0.09
Fwd EY6.93%
FCF(TTM)0.15
FCFY11.83%
OCF(TTM)0.15
OCFY12.32%
SpS0.63
BVpS1.31
TBVpS-0.25
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -0.08%
ROE -0.15%
ROCE 3.32%
ROIC 2.54%
ROICexc 3.2%
ROICexgc 54.14%
OM 10.97%
PM (TTM) N/A
GM 70.81%
FCFM 22.94%
ROA(3y)6.34%
ROA(5y)7.22%
ROE(3y)13.59%
ROE(5y)18.06%
ROIC(3y)8.4%
ROIC(5y)9.93%
ROICexc(3y)11%
ROICexc(5y)12.02%
ROICexgc(3y)125.03%
ROICexgc(5y)244.84%
ROCE(3y)11%
ROCE(5y)12.99%
ROICexcg growth 3Y-27.54%
ROICexcg growth 5Y-25.57%
ROICexc growth 3Y-37.52%
ROICexc growth 5Y-59.98%
OM growth 3Y-33.32%
OM growth 5Y-23.34%
PM growth 3Y-49.98%
PM growth 5Y-35.41%
GM growth 3Y-3.57%
GM growth 5Y-2.1%
F-Score5
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.4
Debt/FCF 3.63
Debt/EBITDA 3.53
Cap/Depr 7.58%
Cap/Sales 0.95%
Interest Coverage 0.85
Cash Conversion 101.42%
Profit Quality N/A
Current Ratio 3.86
Quick Ratio 3.2
Altman-Z 1.91
F-Score5
WACC7.93%
ROIC/WACC0.32
Cap/Depr(3y)7.27%
Cap/Depr(5y)5.1%
Cap/Sales(3y)0.78%
Cap/Sales(5y)0.53%
Profit Quality(3y)364.56%
Profit Quality(5y)302.34%
High Growth Momentum
Growth
EPS 1Y (TTM)-42.86%
EPS 3Y-54.93%
EPS 5Y-20.1%
EPS Q2Q%-33.33%
EPS Next Y-30.45%
EPS Next 2Y-11.97%
EPS Next 3Y-4.14%
EPS Next 5YN/A
Revenue 1Y (TTM)-3.44%
Revenue growth 3Y-10.94%
Revenue growth 5Y23.32%
Sales Q2Q%2.25%
Revenue Next Year2.86%
Revenue Next 2Y2.86%
Revenue Next 3Y2.92%
Revenue Next 5Y29.95%
EBIT growth 1Y-49.69%
EBIT growth 3Y-40.62%
EBIT growth 5Y-5.47%
EBIT Next Year-15.03%
EBIT Next 3Y-1.94%
EBIT Next 5YN/A
FCF growth 1Y-51.1%
FCF growth 3Y-11.33%
FCF growth 5Y21.31%
OCF growth 1Y-50.02%
OCF growth 3Y-10.57%
OCF growth 5Y22.16%